Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
August 16, 2022
Patent Application Number
16500770
Date Filed
April 5, 2018
Patent Citations
Patent Citations Received
Patent Primary Examiner
The present invention relates to products and compositions and their uses. In particular the invention relates to nucleic acid products that interfere with target gene expression or inhibit target gene expression and therapeutic uses of such products.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
